Sector ratings Damora Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 10/06/2026 BST			5-day change	1st Jan Change
20.15 ^USD	-3.86%		-9.76%	-12.43%

06-08	TD Cowen Initiates Damora Therapeutics at Buy	MT
05-28	Wedbush Initiates Damora Therapeutics at Outperform With $35 Price Target	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
DAMORA THERAPEUTICS, INC.	1.29B	-	-	-	-	-
ARGENX SE	54.5B		A
WUXI APPTEC CO., LTD.	41.73B		AAA
BIONTECH SE	21.87B	-	-	-		-
INSMED INCORPORATED	21.47B	-	A	-		-
WUXI BIOLOGICS (CAYMAN) INC.	15.79B		AAA
GENMAB A/S	15.29B		A
EXELIXIS, INC.	13.32B		BB
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	11.53B	-	AA	-		-
SUMMIT THERAPEUTICS INC.	11.09B	-	-	-		-
PHARMAESSENTIA CORPORATION	11.63B		AA
AKESO, INC.	10.51B		B
MADRIGAL PHARMACEUTICALS, INC.	11B	-	B	-		-
ARROWHEAD PHARMACEUTICALS, INC.	10.33B	-	BB	-		-
CYTOKINETICS, INCORPORATED	9.29B	-	AA	-		-
CEREVEL THERAPEUTICS HOLDINGS, INC.	8.19B	-	-	-	-	-	-	-
IMMUNITYBIO, INC.	7.59B	-	CCC	-		-
NUVALENT, INC.	9.74B	-	CCC	-		-
BIOCON LIMITED	7.07B		B
REMEGEN CO., LTD.	7.18B		-
Average	15.02B		A
Weighted average by Cap.			A

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!